Clinical Trials Logo

Clinical Trial Summary

This is a multicenter, randomized, double-blind, parallel-group, reference-controlled 4-month pilot safety study to evaluate the effects of specific lipid fractions-enriched infant formulae on growth of infants aged 0-4 months. The study will test the hypothesis that growth of infants fed the specific lipid fractions-enriched infant formulae will be noninferior to growth of infants fed standard infant formula.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)


Related Conditions & MeSH terms


NCT number NCT02111837
Study type Interventional
Source Nestlé
Contact
Status Completed
Phase N/A
Start date November 2009
Completion date December 2010

See also
  Status Clinical Trial Phase
Recruiting NCT06091917 - Modulating Early-life Nutrition for Childhood Obesity Prevention N/A
Recruiting NCT05119166 - International Milk Composition (IMiC) Consortium
Completed NCT02142647 - Effect of Protein From Complementary Foods on Infant Growth, Body Composition and Gut Health N/A
Completed NCT00388141 - Nursing and Nurturing Premature Infants Phase 0
Recruiting NCT04306263 - Effect of a New Infant Formula With Specific Ingredients N/A
Completed NCT01084109 - First Bites: Complementary Feeding - A Global Network Cluster Randomized Controlled Trial Phase 3
Completed NCT02307760 - Evaluation of Human Milk Fortifiers in Preterm Infants N/A
Recruiting NCT03808207 - Human Milk Lipid Profile Assessment and Influences of Mother's Diet N/A
Completed NCT03993860 - Introduction of Fish Early in the Complementary Feeding Period to Improve Infant Growth N/A
Terminated NCT05804214 - Observational Study of Infants Fed With Dairy and Plant Based Infant Formula